Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,445.00
Bid: 4,430.00
Ask: 4,440.00
Change: 50.00 (1.14%)
Spread: 10.00 (0.226%)
Open: 4,515.00
High: 4,515.00
Low: 4,395.00
Prev. Close: 4,395.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Half Trading Statement

6 Oct 2014 07:00

RNS Number : 4631T
Cranswick PLC
06 October 2014
 

 

6 October 2014

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

First half trading statement

 

Cranswick, the UK food producer, today provides an update on trading for the six months ended 30 September 2014.

 

First half performance

 

Trading during the first half of the year has been in line with the Board's expectations.

 

Revenue in the six months ended 30 September 2014 was in line with the same period last year. Growth across most product categories offset lower sales of fresh pork and, as planned, a greater proportion of the Group's own pigs were utilised internally.

 

The markets in which the Group operates continue to be competitive. Operating margins# in the first half are expected to be similar to those achieved in the previous financial year as a whole reflecting the Group's continued focus on operating efficiencies, product quality and innovation. Pig prices eased during the second quarter of the financial year and are now below the record highs seen at this time last year.

 

During the period, the Group has invested further in its asset base to increase capacity and improve efficiency. Work to extend the Delico cooked meats facility in Milton Keynes was completed on time and to budget. The project provides more capacity to meet anticipated sales growth and the investment in advanced cooking and slicing technology will deliver increased throughput and enhanced yields. A major upgrade to the chilling system at the Norfolk primary processing facility, which is nearing completion, will deliver similar benefits.

 

Financial position

 

Net borrowings were down on the previous quarter end and well below those of a year ago, notwithstanding the on-going capital investment programme across the business. The Group is in a sound financial position with committed, unsecured facilities of £120 million, which provide generous headroom going forward.

 

Outlook

 

Cranswick continues to work closely with its customers and maintain its focus on service, quality and innovation to deliver exciting, competitively priced products. This approach, allied to a growing export trade, a broadening product portfolio and an increasing demand for premium British pork products by the UK consumer, leaves the business well-placed to deliver further growth.

 

With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board remains confident in the continued long term success and development of the business.

 

Market conditions through the second half of the year are expected to remain competitive, however with a strong Christmas trading period anticipated in the third quarter of the financial year, the Group is well placed to deliver a full year performance that is in line with the Board's expectations.

 

The Company intends to announce its interim results on 24 November 2014.

 

 

Enquiries:

 

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Sophie Moate

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2014 showed revenues of £995m and profit before tax of £54.8m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

 

# excluding net IAS 41 valuation movement on biological assets in the current and prior financial years and non-recurring items in the prior financial year

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOANRSAARRAA
Date   Source Headline
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company
14th Oct 202211:33 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Oct 202211:31 amRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Oct 20227:00 amRNSTotal Voting Rights
15th Sep 202211:13 amRNSDirector/PDMR Shareholding
15th Sep 202211:12 amRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:43 pmRNSDirector/PDMR Shareholding
13th Sep 20223:42 pmRNSDirector/PDMR Shareholding
9th Sep 202211:14 amRNSDirector/PDMR Shareholding
1st Sep 202210:00 amRNSTotal Voting Rights
31st Aug 20221:40 pmRNSTotal Voting Rights
31st Aug 20221:38 pmRNSAdditional Listing
15th Aug 20228:51 amRNSDirectorship
10th Aug 20222:49 pmRNSDirector/PDMR Shareholding
2nd Aug 20224:16 pmRNSHolding(s) in Company
1st Aug 20224:41 pmRNSPoll Result for 2022 Annual General Meeting
1st Aug 20224:15 pmRNSTotal Voting Rights
1st Aug 20227:00 amRNSFirst quarter trading statement
29th Jul 20221:02 pmRNSDividend Declaration
5th Jul 20223:03 pmRNSDirector/PDMR Shareholding
5th Jul 20223:02 pmRNSDirector/PDMR Shareholding
5th Jul 20223:00 pmRNSDirector/PDMR Shareholding
5th Jul 20222:59 pmRNSDirector/PDMR Shareholding
5th Jul 20222:58 pmRNSDirector/PDMR Shareholding
4th Jul 20221:25 pmRNSTotal Voting Rights
4th Jul 202211:12 amRNSDirector/PDMR Shareholding
4th Jul 202211:10 amRNSDirector/PDMR Shareholding
4th Jul 202211:05 amRNSDirector/PDMR Shareholding
4th Jul 202211:01 amRNSDirector/PDMR Shareholding
28th Jun 20229:44 amRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSDirector Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.